Parkhurst

EVO ICL UNITED STATES LAUNCH: First group of patients race to Parkhurst Nuvision in San Antonio for new LASIK Eye Surgery Alternative

Retrieved on: 
Wednesday, April 6, 2022
Diving, Parkhurst, Strontium 90: Police Academy, David Smith (reality TV star), Blue, Camping, Medicare Physician Group Practice (PGP) Demonstration, Apple, SMILE, Night vision, Lens (anatomy), Astigmatism, RLE, Gray Team, IPhone, Cataract surgery, Reality, Travel, Lens, Surgeon, ICL, GLOBE, Solution, Eye, FDA, EVO, Patient, Telescopic sight, LASIK, PRK

About EVO: Long-term vision correction with the EVO ICL is a quick and effective procedure that offers many benefits.

Key Points: 
  • About EVO: Long-term vision correction with the EVO ICL is a quick and effective procedure that offers many benefits.
  • ABOUT PARKHURST NUVISION: Parkhurst NuVision is widely known as a premier vision correction surgery center and clinical research facility.
  • Parkhurst NuVision proudly serves the community of San Antonio, Texas, as well as the many patients who travel from across the nation for our expertise in eye surgery.
  • Whatever your eye prescription or stage in life, the team at Parkhurst NuVision is here to help you see.

EVO VISIAN® ICL NOW AVAILABLE IN THE US: PARKHURST NUVISION OF SAN ANTONIO TEXAS AMONG FIRST IN THE UNITED STATES TO OFFER THIS EVOLUTIONARY VISION CORRECTION PROCEDURE

Retrieved on: 
Monday, March 28, 2022
Myopia, Parkhurst, Nave, Trial of the century, ASCRS, Refractive surgery, Glaucoma, Medicare Physician Group Practice (PGP) Demonstration, Quality, SMILE, Night vision, Lens (anatomy), Astigmatism, Keratoconus, RLE, Cataract surgery, Quality of life, Cataract, Travel, Technology, Society, ICL, GLOBE, American Society of Cataract and Refractive Surgery, Solution, Duane syndrome, Freedom, Eye, FDA, EVO, Telescopic sight, Health insurance, Life, Patient, MD, LASIK, PRK

San Antonio, Texas, March 28, 2022 (GLOBE NEWSWIRE) -- EVO Visian ICL (referred to as EVO) is an evolutionary innovation in vision correction surgery.

Key Points: 
  • San Antonio, Texas, March 28, 2022 (GLOBE NEWSWIRE) -- EVO Visian ICL (referred to as EVO) is an evolutionary innovation in vision correction surgery.
  • As the highest volume EVO surgeon in the FDA study, Dr. Gregory Parkhurst at Parkhurst NuVision in San Antonio is excited to be at the helm of one of the first vision correction surgery practices in the United States to offer EVO to his patients.
  • Long-term vision correction with the EVO ICL is a quick and effective procedure that offers many benefits.
  • 4 Naves, J. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery.

Greenberg Traurig Adds Shareholder Nicole Kintop Smith in Dallas; Expands Public Finance & Infrastructure Practice

Retrieved on: 
Thursday, September 16, 2021
The Bond Buyer, Education, LLP, Wisconsin Court of Appeals, Sport, GT, Telecommunication, William Mitchell College of Law, Association, Association of Corporate Counsel, Growth, Disclosure, ACRE, Acquisition, Sale, National Association, Lawyer, Marquette University, Biotechnology, Aviation, Insurance, Economic development, Natural Resources, DBA, McCall, City, ACC, Commercial property, Law, WPF, Dallas Bar Association, Technology, Parkhurst, Software, Carbon, Industry, Transport, Video, History, Security (finance)

DALLAS, Sept. 16, 2021 /PRNewswire-PRWeb/ -- The Dallas office of global law firm Greenberg Traurig, LLP has expanded its Public Finance & Infrastructure Practice with the addition of Nicole Kintop Smith as shareholder.

Key Points: 
  • DALLAS, Sept. 16, 2021 /PRNewswire-PRWeb/ -- The Dallas office of global law firm Greenberg Traurig, LLP has expanded its Public Finance & Infrastructure Practice with the addition of Nicole Kintop Smith as shareholder.
  • Kintop Smith joins the firm from Kintop Smith, PC where she was a founder and managing attorney.
  • About Greenberg Traurig, LLP Texas: Texas is important to Greenberg Traurig, LLP and part of its history.
  • About Greenberg Traurig's Public Finance & Infrastucture Practice: Greenberg Traurig, LLP has a national public finance practice that consistently ranks among the top bond, disclosure, and underwriter's counsel firms according to The Bond Buyer's nationwide and statewide rankings.

Parkhurst NuVision Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts

Retrieved on: 
Tuesday, April 23, 2019
Seniors, Women, Surgery, Health, Clinical trials, Optical, Other Health, Consumer, MEN, Senses, Perception, Health, Eye, Ophthalmology, Vision, Intraocular lens, Cataract, Parkhurst, IOL, Clinical trial

Gregory D. Parkhurst, MD at Parkhurst NuVision in San Antonio, Texas, is participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.

Key Points: 
  • Gregory D. Parkhurst, MD at Parkhurst NuVision in San Antonio, Texas, is participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.
  • We have just begun enrolling patients in the IC-8 lens clinical study, Dr. Parkhurst said.
  • Dr. Parkhurst will be one of a select group of clinical investigators across the United States for the IC-8 lens study .
  • If you are interested in becoming a volunteer participant in the IC-8 lens clinical study, please contact Parkhurst NuVision at (844) 834-2020 or online at ParkhurstNuVision.com.